<\/p>\n
Joel S Hirschhorn<\/p>\n<\/div>\n
Americans who have taken COVID vaccine shots and those who have refused to capitulate to the coercion and propaganda are ill-informed about blood clots.\u00a0\u00a0This article provides summaries of key recently published research on two types of observed blood clots \u2013 microscopic and relatively large size \u2013 that merit serious attention and concern.\u00a0\u00a0One inevitable conclusion is that the FDA with support from big media is not doing its job to ensure truly informed consent by those taking vaccine shots.<\/p>\n
Dr Charles Hoffe has been practicing medicine for 28 years in a small, rural town in British Columbia, Canada, and recently gave a\u00a0long interview<\/a>.\u00a0\u00a0He has given about 900 doses of the Moderna experimental mRNA vaccine to his patients.\u00a0\u00a0So, contrary to some critics, he is no anti-vaccine doctor.<\/p>\n The core problem he has seen are microscopic clots in his patients\u2019 tiniest capillaries.\u00a0\u00a0He said \u201cBlood clots occurring at a capillary level.\u00a0\u00a0This has never before been seen. This is not a rare disease.\u00a0\u00a0This is an absolutely new phenomenon.\u201d<\/p>\n Most importantly, he has emphasized these micro-clots are too small to show up on CT scans, MRI, and other conventional tests, such as angiograms, and can only be detected using the D-dimer blood test.\u00a0\u00a0Using the latter, he found that 62% of his patients injected with an mRNA shot are positive for clotting.\u00a0\u00a0He has explained what is happening in bodies.\u00a0\u00a0The spike proteins in the vaccine become \u201cpart of the cell wall of your vascular endothelium.\u00a0\u00a0This means that these cells which line your blood vessels, which are supposed to be smooth so that your blood flows smoothly now have these little spikey bits sticking out.\u00a0\u00a0\u2026 when the platelet comes through the capillary it suddenly hits all these COVID spikes and it becomes absolutely inevitable that blood clots will form to block that vessel.\u201d<\/p>\n He made an important distinction: \u201cThe blood clots we hear about which the media claim are very rare are the big blood clots which are the ones that cause strokes and show up on CT scans, MRI, etc.\u00a0\u00a0The clots I\u2019m talking about are microscopic and too small to find on any scan.\u00a0\u00a0They can thus only be detected using the D-dimer test\u2026The most alarming part of this is that there are some parts of the body like the brain, spinal cord, heart and lungs which cannot re-generate. When those tissues are damaged by blood clots they are permanently damaged.\u201d<\/p>\n This is his pessimistic, scientific view: \u201cblood vessels in their lungs are now blocked up.\u00a0\u00a0In turn, this causes the heart to need to work harder to try to keep up against a much greater resistance trying to get the blood through your lungs.\u00a0\u00a0This is called pulmonary artery hypertension \u2013 high blood pressure in the lungs because the blood simply cannot get through effectively.\u00a0\u00a0People with this condition usually die of heart failure within a few short years.\u201d<\/p>\n All these medical views have been suppressed by big media., but it was covered well in another\u00a0alternative news site.<\/a>\u00a0\u00a0And the doctor got some attention by submitting an\u00a0open letter<\/a>\u00a0to the provincial Ministry of Health.\u00a0\u00a0A key point in that is this: \u201cIt must be emphasised, that these people were not sick people, being treated for some devastating disease.\u00a0These were previously healthy people, who were offered an experimental therapy, with unknown long-term side-effects, to protect them against an illness that has the same mortality rate as the flu. Sadly, their lives have now been ruined.\u201d<\/p>\n The concept of micro blood clots has also been invoked for the serious impacts of COVID itself.\u00a0\u00a0The eminent Dr. Peter McCullough\u00a0noted<\/a>\u00a0\u201cSo, this is a very different type of blood clotting that we would see with major blood clots in the arteries and veins.\u00a0\u00a0For instance, blood clots involved in stroke and heart attack.\u00a0\u00a0Blood clots involved in major blood vessels in the legs.\u00a0\u00a0This was a different type of clotting and in fact the Italians courageously did some autopsies and found micro blood clots in the lungs.\u00a0\u00a0And so, we understood in the end, the reason why the lungs fail is not because the virus is there.\u00a0\u00a0It is because micro blood clots are there.\u00a0\u00a0\u2026 When People can\u2019t breathe, the problem is micro-blood clotting in the lungs.\u00a0\u00a0\u2026The spicule on the ball of the of the virus itself which damages blood vessels that causes blood clotting.\u201d\u00a0\u00a0He has also openly stated that none of the COVID vaccines are safe for most people at little risk from COVID.<\/p>\n If spike protein is the cause of micro blood clots in COVID it is also reasonable to see the same phenomenon in vaccinated people impregnated with spike proteins, as Dr. Hoffe as explained.<\/p>\n As to the Canadian situation,\u00a0The Public Health Agency of Canada (PHAC)\u00a0in July estimated the rate of vaccine-related blood clotting in Canadians who have received the AstraZeneca vaccine and said there have been 27 confirmed cases to date in Canada, with five deaths among those cases, a rather high death rate.<\/p>\n But this is consistent with 6 out of 28 blood clot cases\u00a0reported<\/a>\u00a0by Yale University for the J&J vaccine in the US\u00a0\u00a0Also noted was that these were a particularly rare and dangerous blood clot in the brain, known as\u00a0cerebral venous sinus thrombosis (CVST), because it appears in the brain\u2019s venous sinuses\u00a0\u00a0Also noted that there were abnormally low platelet levels in their blood, an unusual situation also found for those impacted by the AstraZeneca vaccine.<\/p>\n To its credit, the Wall Street Journal published a\u00a0long article<\/a>\u00a0in July on the COVID vaccine blood clot issue.\u00a0\u00a0Here are highlights from it.<\/p>\n \u201cCanadian researchers say they have pinpointed a handful of amino acids targeted by key antibodies in the blood of some people who received the AstraZeneca Covid-19 vaccine, offering fresh clues to what causes rare blood clots associated with the shot.\u201d<\/p>\n \u201cThe peer-reviewed findings, by a team of researchers from McMaster University in Ontario, were published \u2026by the\u00a0science journal Nature<\/a>.\u00a0\u00a0They could help doctors rapidly test for and treat the unusual clotting, arising from an immune-driven mix of coagulation and loss of platelets that stop bleeding.\u201d<\/p>\n \u201cThe blood clotting, which some scientists have named vaccine-induced immune thrombotic thrombocytopenia, or VITT, has also been linked to Johnson & Johnson\u2019s Covid-19 shot, though incidents have occurred less frequently with that shot than with AstraZeneca.\u201d<\/p>\n \u201cThough rare, the condition has proven deadly in more than 170 adults post-vaccination in the U.K., Europe and U.S., according to government tallies.\u00a0\u00a0Many were younger adults who appeared healthy before vaccination, researchers and drug regulators say.\u201d<\/p>\n \u201cThe total number of cases after first or second doses in the U.K. was 395 through June 23\u2026Of the 395, 70 people have died.\u00a0\u00a0European officials said this month that they have seen 479 potential cases of VITT out of 51.4 million AstraZeneca vaccinations\u2026Far fewer potential cases\u201421 \u2026followed J&J vaccinations in Europe.\u00a0\u00a0Of those cases, 100 deaths occurred after AstraZeneca vaccination and four after Johnson & Johnson, European regulators said.\u201d<\/p>\n \u201cU.S. health officials said in late June that they have identified 38 confirmed cases of the blood-clotting syndrome out of more than 12.3 million people who received the J&J vaccine\u2026The Centers for Disease Control and Prevention said in May that three cases had been fatal and evidence \u2018suggests a plausible causal association\u2019 between the combination of low platelets and clotting and the vaccine.\u201d<\/p>\n As to what is going on inside the body: \u201c[In] rare cases, vaccinated people have experienced an autoimmune reaction in which antibodies bind with unusual strength to a blood component called platelet factor 4, or PF4, forming distinct clusters resembling a bunch of grapes.\u00a0\u00a0This so-called immune complex, a molecular formation in the blood, activates more platelets, \u2018like putting a match to gasoline,\u2019 said John Kelton, an author of the Nature paper and researcher at McMaster University.\u00a0\u00a0The process accelerates, he and other researchers say, triggering simultaneous bleeding and clotting, sometimes in the brain, stomach and other areas that can in rare cases be deadly. \u2018We think these antibodies are incredible amplifiers, in a bad way, of the normal coagulation system,\u2019 says Dr. Kelton\u201d<\/p>\n Interestingly, this article did not mention at all the previously discussed case of the Canadian doctor and his findings about microscopic blood clotting.<\/p>\n In April, there was limited\u00a0coverage<\/a>\u00a0of stoppages of some vaccines: \u201cFirst it was AstraZeneca. Now Johnson & Johnson.\u00a0Last week, British regulators and the European Union\u2019s medical agency said they had established a possible link between AstraZeneca\u2019s Covid-19 vaccine and very rare, though sometimes fatal, blood clots.\u00a0\u00a0The pause in the use of Johnson & Johnson\u2019s vaccine in Europe over similar concerns threatens to hurt a sluggish rollout that was just starting to gain momentum.\u201d\u00a0\u00a0Also noted was that states paused use of the J&J vaccine after a US advisory.<\/p>\n \u201cRegulators have asked vaccine recipients and doctors to look out for certain symptoms, including severe and persistent headaches and tiny blood spots under the skin.\u201d<\/p>\n In April this journal published three research articles on blood clotting related to COVID vaccines and a long\u00a0editorial<\/a>\u00a0by two physicians reviewing all the work.\u00a0\u00a0Here are highlights from the latter.<\/p>\n \u201cThe Journal has now highlighted three independent descriptions of 39 persons with a newly described syndrome characterized by thrombosis and thrombocytopenia that developed 5 to 24 days after initial vaccination with [the AstraZeneca vaccine].\u00a0\u00a0\u2026 These persons were healthy or in medically stable condition, and very few were known to have had previous thrombosis or a preexisting prothrombotic condition.\u00a0\u00a0Most of the patients included in these reports were women younger than 50 years of age, some of whom were receiving estrogen-replacement therapy or oral contraceptives.\u00a0\u00a0A remarkably high percentage of the patients had thromboses at unusual sites \u2014 specifically, cerebral venous sinus thrombosis or thrombosis in the portal, splanchnic, or hepatic veins.\u00a0\u00a0Other patients presented with deep venous thrombi, pulmonary emboli, or acute arterial thromboses.\u00a0\u00a0\u2026 High levels of d-dimers and low levels of fibrinogen were common and suggest systemic activation of coagulation.\u00a0\u00a0Approximately 40% of the patients died, some from ischemic brain injury, superimposed hemorrhage, or both conditions, often after anticoagulation.\u201d<\/p>\n \u201cBetter understanding of how the vaccine induces these platelet-activating antibodies might also provide insight into the duration of antigen exposure and the risk of reoccurrence of thrombosis, which will inform the need for extended anticoagulation and might lead to improvements in vaccine design.\u201d<\/p>\n \u201cAdditional cases have now been reported to the European Medicines Agency, including at least 169 possible cases of cerebral venous sinus thrombosis and 53 possible cases of splanchnic vein thrombosis among 34 million recipients of the [AstraZeneca] vaccine, 35 possible cases of central nervous system thrombosis among 54 million recipients of the Pfizer\u2013BioNTech mRNA vaccine, and 5 possible (but unvetted) cases of cerebral venous sinus thrombosis among 4 million recipients of the Moderna mRNA vaccine.\u00a0\u00a0Six possible cases of cerebral venous sinus thrombosis (with or without splanchnic vein thrombosis) have been reported among the more than 7 million recipients of the Johnson & Johnson\/Janssen vaccine.\u201d<\/p>\n Here is the final conclusion; \u201cThe questions of whether certain populations can be identified as more suitable candidates for one or another vaccine and who and how to monitor for this rare potential complication will require additional study.\u201d<\/p>\n In April, the Salk Institute\u00a0promoted coverage<\/a>\u00a0of research conducted by a number of people associated with it.\u00a0\u00a0The chief finding was that the spike protein associated with the COVID virus and with vaccines was connected to strokes, heart attacks and blood clots.<\/p>\n \u201cThe paper, published in\u00a0Circulation Research<\/a>, also shows conclusively that COVID-19 is a vascular disease, demonstrating exactly how the SARS-CoV-2 virus damages and attacks the vascular system on a cellular level.\u00a0\u00a0\u2026 the paper provides clear confirmation and a detailed explanation of the mechanism through which the [spike] protein damages vascular cells.\u201d<\/p>\n A\u00a0subsequent article<\/a>\u00a0in May examined this work and made several important observations.\u00a0\u00a0Here is its perspective, as relevant to the COVID vaccines.\u00a0\u00a0\u201cThe prestigious Salk Institute\u2026has authored and published the bombshell scientific study revealing that the SARS-CoV-2 spike protein used in the Covid jabs is what\u2019s actually causing vascular damage.\u00a0\u00a0Critically, all three of the experimental Covid vaccines currently under emergency use authorisation in the UK either inject patients with the spike protein or, via mRNA technology, instruct the patient\u2019s own body to manufacture the spike protein and release them into the blood system.\u201d<\/p>\n \u201cThe Salk Institute study proves the assumption made by the vaccine industry, that the spike protein is inert and harmless, to be false and dangerously inaccurate.\u201d<\/p>\n \u201cThe research proves that the Covid vaccines are capable of inducing vascular disease and directly causing injuries and deaths stemming to blood clots and other vascular reactions.\u00a0\u00a0This is all caused by the spike protein that\u2019s engineered into the vaccines.\u201d<\/p>\n This May\u00a0report<\/a>\u00a0was prepared by nearly five dozen highly respected doctors, scientists, and public policy experts from across the globe.\u00a0\u00a0It went public and was urgently sent to world leaders as well as all who are associated with the production and distribution of the various Covid-19 vaccines in circulation today.\u00a0\u00a0The report demanded an immediate stop to COVID vaccinations.\u00a0\u00a0Dr. McCullough was one of the signatories.<\/p>\n \u201cDespite calls for caution, the risks of SARS-CoV-2 vaccination have been minimized or ignored by health organizations and government authorities,\u201d said the experts.<\/p>\n On the issue of blood clotting in vaccinated people the report said this:<\/p>\n \u201cSome adverse reactions, including blood-clotting disorders, have already been reported in healthy and young vaccinated people. These cases led to the suspension or cancellation of the use of adenoviral vectorized [AstraZeneca] and [J&J] vaccines in some countries.\u00a0\u00a0It has now been proposed that vaccination with ChAdOx1-nCov-19 can result in immune thrombotic thrombocytopenia (VITT) mediated by platelet-activating antibodies against Platelet factor-4, which clinically mimics autoimmune heparin-induced thrombocytopenia.\u00a0\u00a0 Supporters of the COVID vaccines are quick to emphasize that relatively few recipients have experienced post-vaccination blood clotting.\u00a0\u00a0True, except for the findings of the Canadian physician about microscopic blood clots in most of his patients that major news media have ignored.\u00a0\u00a0Also ignored are the findings from the Salk Institute which provide a rationale for seeing spike proteins as causing clots.\u00a0\u00a0Even vaccines not directly including spike proteins \u2013 the AstraZeneca and J&J adenovirus vector vaccines \u2013 pose a problem because they send genetic instructions into cells to produce the spike protein of the coronavirus.<\/p>\n Even a June\u00a0case study<\/a>\u00a0of one patient who died from clotting after taking the second dose of the Moderna vaccine and not related to anything else stressed the use of \u201csafe\u201d COVID vaccines.\u00a0\u00a0This was also stressed in an accompanying\u00a0editorial<\/a>\u00a0that mentioned: \u201cThe highest reported incidence is 5 cases among about 130,000 Norwegian recipients of the [AstraZeneca] vaccine.\u201d\u00a0\u00a0This statistical view of the medical establishment was expressed as: \u201cany potential risks of vaccination must be interpreted in the context of the overall morbidity and mortality of COVID-19 itself.\u201d\u00a0\u00a0It also stressed blood clots in hospitalized COVID patients.\u00a0\u00a0It cannot be emphasized enough that the vast majority of COVID victims could have been saved through early home\/outpatient treatment as detailed in\u00a0Pandemic Blunder<\/a>.\u00a0\u00a0The proven treatments can stop COVID infection in its early virus replication phase and, therefore, prevent blood clots.<\/p>\n The public also needs strong information about the many advantages of natural immunity, from prior COVID infection or life exposure to various coronaviruses.\u00a0\u00a0This is far better than vaccine induced artificial immunity that does less to protect against COVID variants and makes people susceptible to breakthrough infections.\u00a0\u00a0For most people the benefits of COVID vaccination do not outweigh the risks.<\/p>\n On the issue of whether all COVID vaccines pose a blood clot threat consider an April\u00a0study by Oxford University<\/a>\u00a0that found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer and Moderna vaccines as they are for the AstraZeneca vaccine.\u00a0\u00a0And as already cited the J&J vaccine has also been implicated for clots.<\/p>\n What needs attention by FDA, CDC and NIH is the need to do more testing of vaccine victims to discover through blood testing or autopsies the nature and extent of blood clotting.<\/p>\nWall Street Journal and Nature Journal<\/u><\/strong><\/h2>\n
New York Times<\/u><\/strong><\/h2>\n
New England Journal of Medicine<\/u><\/strong><\/h2>\n
Salk Institute<\/u><\/strong><\/h2>\n
Report by 57 Medical Experts<\/u><\/strong><\/h2>\n
Conclusions<\/u><\/strong><\/h2>\n